[
1. World Health Organization. Global diffusion of eHealth: making universal health coverage achievable: report of the third global survey on eHealth. World Health Organization, 2017.
]Search in Google Scholar
[
2. Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol. 2013;168:934-945.10.1016/j.ijcard.2012.10.046
]Search in Google Scholar
[
3. Kannel WB, Abbott RD, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982;306:1018-22.10.1056/NEJM198204293061703
]Search in Google Scholar
[
4. Kralev S, Schneider K, et al. Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography. PLoS One. 2011;6:e24964.10.1371/journal.pone.0024964
]Search in Google Scholar
[
5. Golia E, Limongelli G, Natale F, et al. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr Atheroscler Rep. 2014;16:435.10.1007/s11883-014-0435-z
]Search in Google Scholar
[
6. Goldberger JJ, Cain ME, Hohnloser SH, et al. American Heart Association/ American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation. 2008;118:1497-518.10.1161/CIRCULATIONAHA.107.189375
]Search in Google Scholar
[
7. Schmermund A, Eckert J, Schmidt M, et al. Coronary computed tomography angiography: a method coming of age. Clin Res Cardiol. 2018;107:40-48.10.1007/s00392-018-1320-5
]Search in Google Scholar
[
8. Hadamitzky M, Taubert S, Deseive S, et al. Prognostic value of coronary computed tomography angiography during 5 years of follow-up in patients with suspected coronary artery disease. Eur Heart J. 2013;34:3277-3285.10.1093/eurheartj/eht293
]Search in Google Scholar
[
9. Hadamitzky M, Achenbach S, Al-Mallah M, et al. Optimized prognostic score for coronary computed tomographic angiography: results from the CONFIRM registry (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry). J Am Coll Cardiol. 2013;62:468-476.10.1016/j.jacc.2013.04.064
]Search in Google Scholar
[
10. SCOT-HEART investigators. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet. 2015;385:2383-2391.10.1016/S0140-6736(15)60291-4
]Search in Google Scholar
[
11. Newby DE, Adamson PD, Berry C, et al. SCOT-HEART Investigators. Coronary CT angiography and 5-year risk of myocardial infarction. N Engl J Med. 2018;379:924-933.10.1056/NEJMoa180597130145934
]Search in Google Scholar
[
12. Adamson PD, Williams MC, Dweck MR, et al. SCOT-HEART Investigators. Guiding therapy by coronary CT angiography improves outcomes in patients with stable chest pain. J Am Coll Cardiol. 2019;74:2058-2070.10.1016/j.jacc.2019.07.085689944631623764
]Search in Google Scholar
[
13. Douglas PS, Hoffmann U, Patel MR, et al. PROMISE Investigators. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med. 2015;372:1291-1300.10.1056/NEJMoa1415516447377325773919
]Search in Google Scholar
[
14. Budoff MJ, Dowe D, et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol. 2008;52:1724-1732.10.1016/j.jacc.2008.07.03119007693
]Search in Google Scholar
[
15. Maurovich-Horvat P, Ferencik M, et al. Comprehensive plaque assessment by coronary CT angiography. Nat Rev Cardiol. 2014;11:390-402.10.1038/nrcardio.2014.6024755916
]Search in Google Scholar
[
16. Miller JM, Rochitte CE, et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med. 2008;359:2324-2336.10.1056/NEJMoa080657619038879
]Search in Google Scholar
[
17. Nerlekar N, Ha FJ, et al. Computed tomographic coronary angiography-derived plaque characteristics predict major adverse cardiovascular events: a systematic review and meta-analysis. Circ Cardiovasc Imaging. 2018;10:e006973.10.1161/CIRCIMAGING.117.00697329305348
]Search in Google Scholar
[
18. Soraya T. Inflammation in atherosclerosis. Elsevier. 2016;109(12):708-715.
]Search in Google Scholar
[
19. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol. 2009;27:165-197.10.1146/annurev.immunol.021908.132620273440719302038
]Search in Google Scholar
[
20. Arida A, Protogerou AD, et al. Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases. Int J Mol Sci. 2018;19:1890.10.3390/ijms19071890607340729954107
]Search in Google Scholar
[
21. Aviña-Zubieta JA, Choi HK, Sadatsafavi M, et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis Care Res. 2008;59:1690-1697.10.1002/art.2409219035419
]Search in Google Scholar
[
22. Rodean IP, Lazar L, Opincariu D, et al. Association between periodontal disease, coronary calcium score and markers of subclinical atherosclerosis in patients with unstable angina – a CT-based sub-study from the ATHERODENT clinical trial. European Heart Journal – Cardiovascular Imaging. 2020;21:jez319.299.10.1093/ehjci/jez319.299
]Search in Google Scholar
[
23. Dorn SD, Sandler RS. Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. Am J Gastroenterol. 2007;102:662-667.10.1111/j.1572-0241.2006.01018.x17156143
]Search in Google Scholar
[
24. Zanoli L, Signorelli SS, Inserra G, Castellino P. Subclinical Atherosclerosis in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Angiology. 2017;68:463.10.1177/000331971667507627784730
]Search in Google Scholar
[
25. Kristensen SL, Ahlehoff O, Lindhardsen J, et al. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death – a Danish nationwide cohort study. PLoS One. 2013;8:e56944.10.1371/journal.pone.0056944357407923457642
]Search in Google Scholar
[
26. Yarur AJ, Deshpande AR, Pechman DM, et al. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol. 2011;106:741-747.10.1038/ajg.2011.6321386828
]Search in Google Scholar
[
27. Aniwan S, Pardi DS, Tremaine WJ, Loftus EV Jr. Increased Risk of Acute Myocardial Infarction and Heart Failure in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2018;16:1607-1615.10.1016/j.cgh.2018.04.031615282829702298
]Search in Google Scholar
[
28. Kirchgesner J, Beaugerie L, Carrat F for the BERENICE study group, et al. Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study. Gut. 2018;67:1261-1268.10.1136/gutjnl-2017-31401528647686
]Search in Google Scholar
[
29. Tsai MS, Lin CL, Chen HP, Lee PH, Sung FC, Kao CH. Long-term Risk of Acute Coronary Syndrome in Patients with Inflammatory Bowel Disease: A 13-year Nationwide Cohort Study in an Asian Population. Inflammatory Bowel Diseases. 2014;20:502-507.10.1097/01.MIB.0000441200.10454.4f24412991
]Search in Google Scholar
[
30. Weissman S, Sinh P, Mehta TI, et al. Atherosclerotic cardiovascular disease in inflammatory bowel disease: The role of chronic inflammation. World J Gastrointest Pathophysiol. 2020;11:104-113.10.4291/wjgp.v11.i5.104740375332832194
]Search in Google Scholar
[
31. Wang H, Liu Z, Shao J, et al. Immune and Inflammation in Acute Coronary Syndrome: Molecular Mechanisms and Therapeutic Implications. J Immunol Res. 2020;2020:4904217.10.1155/2020/4904217745030932908939
]Search in Google Scholar
[
32. Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its resolution as determinants of acute coronary syndromes. Circulation Research. 2014;114:1867-1879.10.1161/CIRCRESAHA.114.302699407876724902971
]Search in Google Scholar
[
33. Lahdentausta L, Leskelä J, Winkelmann A, et al. Serum MMP-9 diagnostics, prognostics, and activation in acute coronary syndrome and its recurrence. Journal of Cardiovascular Translational Research. 2018;11:210-220.10.1007/s12265-018-9789-x
]Search in Google Scholar
[
34. Kai H, Ikeda H, Yasukawa H, et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol. 1998;32:368-372.10.1016/S0735-1097(98)00250-2
]Search in Google Scholar
[
35. Inokubo Y, Hanada H, Ishizaka H, Fukushi T, Kamada T, Okumura K. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. American Heart Journal. 2001;141:211-217.10.1067/mhj.2001.11223811174334
]Search in Google Scholar
[
36. Derosa G, D’Angelo A, Scalise F, et al. Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome. Heart and Vessels. 2007;22:361-370.10.1007/s00380-007-0989-618043992
]Search in Google Scholar
[
37. Dumitriu IE, Baruah P, Finlayson CJ, et al. High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome. Circulation Research. 2012;110:857-869.10.1161/CIRCRESAHA.111.26193322282196
]Search in Google Scholar
[
38. Saigusa R, Winkels H, Ley K. T cell subsets and functions in atherosclerosis. Nature Reviews Cardiology. 2020;17:387-401.10.1038/s41569-020-0352-5787221032203286
]Search in Google Scholar
[
39. Rezaee-Zavareh MS, Tohidi M, Sabouri A, Ramezani-Binabaj M, Sadeghi-Ghahrodi M, Einollahi B. Infectious and coronary artery disease. ARYA Atheroscler. 2016;12:41-49.
]Search in Google Scholar
[
40. Higuchi ML, Ramires JAF. Infectious agents in coronary atheromas: a possible role in the pathogenesis of plaque rupture and acute myocardial infarction. Revista do Instituto de Medicina Tropical de São Paulo. 2002;44:217-224.10.1590/S0036-46652002000400007
]Search in Google Scholar
[
41. Shah PK. Plaque disruption and thrombosis: potential role of inflammation and infection. Cardiol Rev. 2000;8:31-39.10.1097/00045415-200008010-00007
]Search in Google Scholar
[
42. Pesonen E, El-Segaier M, Persson K, et al. Infections as a stimulus for coronary occlusion, obstruction, or acute coronary syndromes. Therapeutic Advances in Cardiovascular Disease. 2009;3:447-454.10.1177/175394470934559819773293
]Search in Google Scholar
[
43. Thygesen K, Alpert JS, Jaffe AS, et al. Third Universal Definition of Myocardial Infarction. Circulation. 2012;126:2020-2035.10.1161/CIR.0b013e31826e105822923432
]Search in Google Scholar
[
44. Musher DM, Abers MS, Corrales-Medina VF. Acute Infection and Myocardial Infarction. N Engl J Med. 2019;380:171-176.10.1056/NEJMra180813730625066
]Search in Google Scholar
[
45. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-97910.1056/NEJM1997040333614019077376
]Search in Google Scholar
[
46. Ridker P, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-843.10.1056/NEJM20000323342120210733371
]Search in Google Scholar
[
47. Ridker PM. High sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;103:1813-1818.10.1161/01.CIR.103.13.181311282915
]Search in Google Scholar
[
48. Ridker P, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557-1565.10.1056/NEJMoa02199312432042
]Search in Google Scholar
[
49. Ridker PM, Buring JE, Cook NR, et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation. 2003;107:391-397.10.1161/01.CIR.0000055014.62083.05
]Search in Google Scholar
[
50. Koenig W, Sund M, Fröhlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation. 1999;99:237-242.10.1161/01.CIR.99.2.237
]Search in Google Scholar
[
51. Coelho Graça D, Golaz O, Magnin J-L, et al. CRP-Based Cardiovascular Risk Assessment: New Conventional CRP Assay Fit for Purpose? The Journal of Applied Laboratory Medicine. 2018;2:952-959.
]Search in Google Scholar
[
52. Danesh J, Wheeler JG, Hirschfield GM. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387-1397.10.1056/NEJMoa03280415070788
]Search in Google Scholar
[
53. Wang TJ, Gona P, Larson MG. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355:2631-2639.10.1056/NEJMoa05537317182988
]Search in Google Scholar
[
54. Blankenberg S, Zeller T, Saarela O. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation. 2010;121:2388-2397.10.1161/CIRCULATIONAHA.109.90141320497981
]Search in Google Scholar
[
55. Seo WW, Kim H-L, Kim Y-J, et al. Incremental prognostic value of high-sensitive C-reactive protein in patients undergoing coronary computed tomography angiography. Journal of Cardiology. 2016;68:222-22810.1016/j.jjcc.2015.09.010
]Search in Google Scholar
[
56. Kubo T, Matsuo Y, Hayashi Y, et al. High-sensitivity C-reactive protein and plaque composition in patients with stable angina pectoris: a virtual histology intravascular ultrasound study. Coron Artery Dis. 2009;20:531-535.10.1097/MCA.0b013e328332a6b0
]Search in Google Scholar
[
57. Sanchís J, Bodí V, Llácer A, et al. Relación de los valores de proteína C reactiva con los hallazgos angiográficos y los marcadores de necrosis en el síndrome coronario agudo sin elevación del segmento ST. Rev Esp Cardiol. 2004;57:382-387.10.1016/S0300-8932(04)77122-5
]Search in Google Scholar
[
58. Inoue T, Kato T, Uchida T, et al. Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting. J Am Coll Cardiol. 2005;46:239-245.10.1016/j.jacc.2005.04.02916022949
]Search in Google Scholar
[
59. Mani P, Puri R, Schwartz GG, et al. Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial. JAMA Cardiol. 2019;4:314-320.10.1001/jamacardio.2019.0179648478530840024
]Search in Google Scholar
[
60. Lucci C, Cosentino N, Genovese S, et al. Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus. Cardiovasc Diabetol. 2020;19:183.10.1186/s12933-020-01157-7757682033081810
]Search in Google Scholar
[
61. Suleiman M, Aronson D, Reisner SA, et al. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med. 2003;115:695-701.10.1016/j.amjmed.2003.06.00814693321
]Search in Google Scholar
[
62. Morariu M, Márton E, Mester A, et al. Association Between Acute Inflammatory Response and Infarct Size in Stemi Patients Undergoing Primary PCI. Journal Of Cardiovascular Emergencies. 2018;4:140-146.10.2478/jce-2018-0017
]Search in Google Scholar
[
63. Lazzerini PE, Capecchi PL, Laghi-Pasini F. Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur Heart J. 2017;38:1717-1727.
]Search in Google Scholar
[
64. Ungprasert P, Srivali N, Kittanamongkolchai W. Risk of incident atrial fibrillation in patients with rheumatoid arthritis: a systematic review and meta-analysis. Int J Rheum Dis. 2017;20:434-441.10.1111/1756-185X.1282026692475
]Search in Google Scholar
[
65. Ahlehoff O, Gislason GH, Jørgensen CH, et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a danish nationwide cohort study. Eur Heart J. 2012;33:2054-2064.10.1093/eurheartj/ehr28521840930
]Search in Google Scholar
[
66. Efe TH, Cimen T, Ertem AG, et al. Atrial Electromechanical properties in inflammatory bowel disease. Echocardiography. 2016;33:1309-1316.10.1111/echo.1326127158773
]Search in Google Scholar
[
67. Seferović PM, Ristić AD, Maksimović R, et al. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology. 2006;45:39-42.10.1093/rheumatology/kel31516980722
]Search in Google Scholar
[
68. Korantzopoulos P, Letsas KP, Tse G, et al. Inflammation and atrial fibrillation: A comprehensive review. J Arrhythm. 2018;34:394-401.10.1002/joa3.12077611147730167010
]Search in Google Scholar
[
69. Wu N, Xiang Y, Wu L, et al. Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: A meta-analysis. Int J Cardiol. 2013;169:62-72.10.1016/j.ijcard.2013.08.07824095158
]Search in Google Scholar
[
70. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104:2886-2891.10.1161/hc4901.10176011739301
]Search in Google Scholar
[
71. Rienstra M, Sun JX, Magnani JW, et al. White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study). Am J Cardiol. 2012;109:533-537.10.1016/j.amjcard.2011.09.049327011822100030
]Search in Google Scholar
[
72. Weymann A, Ali-Hasan-Al-Saegh S, Sabashnikov A, et al. Prediction of new-onset and recurrent atrial fibrillation by complete blood count tests: a comprehensive systematic review with meta-analysis. Med Sci Monit Basic Res. 2017;23:179-222.10.12659/MSMBR.903320543953528496093
]Search in Google Scholar
[
73. Shao Q, Chen K, Rha SW, Lim HE, Li G, Liu T. Usefulness of neutrophil/ lymphocyte ratio as a predictor of atrial fibrillation: a meta-analysis. Arch Med Res. 2015;46:199-206.10.1016/j.arcmed.2015.03.01125980945
]Search in Google Scholar
